Skip to content

Clinical efficacy of amlodipine and benazepril hydrochloride tablets in controlling morning blood pressure surge (MBPS) in patients with arteriosclerosis

Clinical efficacy of amlodipine and benazepril hydrochloride tablets in controlling morning blood pressure surge (MBPS) in patients with arteriosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091651
Enrollment
Unknown
Registered
2024-10-31
Start date
2021-11-18
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Group A (Amlodipine besylate and benazepril hydrochloride):Amlodipine besylate and benazepril hydrochloride tablet 1 tablet per day
Group A (Amlodipine and Bisoprolol):Amlodipine and Bisoprolo tablet 1 tablet per day

Sponsors

Shaoxing Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Over 18 years old; 2. Meets the "WHO/ISH" diagnostic criteria for hypertension; 3. The patient agrees to sign an informed consent form; 4. Clinical conditions require drug combination therapy; 5. Having characteristics of arteriosclerosis, including: 1) Carotid atherosclerosis: Carotid ultrasound IMT = 0.9mm or atherosclerotic plaque; Carotid artery stenosis; History of carotid artery revascularization; 2) Arteriosclerosis of lower limbs: arterial plaque of lower limbs or ankle brachial index<0.9; Lower limb arterial stenosis; History of lower limb revascularization; 3) Aortic syndrome: aortic atherosclerosis; Aortic intramural hematoma; Local aortic ulcer; 4) Coronary atherosclerosis or coronary heart disease: coronary artery plaque or even stenosis is found by coronary artery CT or coronary angiography; Have a history of myocardial infarction or typical angina pectoris; Have a history of coronary artery revascularization. 5) History of stroke or TIA: including ischemic stroke and TIA; 6) Fundus arteriosclerosis: Scheie grade 2 or above in the fundus;

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension; 2. Severe cardiovascular and cerebrovascular diseases; 3. Severe liver and kidney dysfunction; 4. History of allergies or significant adverse reactions to experimental or observation group drugs; 5. Known malignant tumors, severe hematological disorders, or active rheumatism.

Design outcomes

Primary

MeasureTime frame
Morning BP;Ambulatory blood pressure;

Countries

China

Contacts

Public ContactJianyao Shen

Shaoxing Central Hospital (The Central Affiliated Hospital, Shaoxing University)

jianyao_s@163.com+86 137 3526 5055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026